CJC 1295 No DAC 5 mg/Ipamorelin 5 mg

Dragon Pharma CJC 1295 No DAC/Ipamorelin Blend

For athletes, bodybuilders, and fitness enthusiasts seeking optimal recovery, lean muscle preservation, and improved sleep quality, growth hormone modulation is a cornerstone of advanced research. CJC 1295 No DAC (a GHRH analog) and Ipamorelin (a GHRP) represent two of the most studied growth hormone secretagogues, each with distinct yet complementary mechanisms. When combined, they create a powerful synergistic effect that mimics the body's natural pulsatile growth hormone release. This Dragon Pharma CJC 1295 No DAC / Ipamorelin 5mg blend offers a convenient pre-mixed formulation with 5mg of each peptide in a single lyophilized vial, providing researchers with a comprehensive tool for advanced growth hormone research.

CJC 1295 No DAC (Mod GRF 1-29) functions as a growth hormone-releasing hormone (GHRH) analog, stimulating the pituitary to release growth hormone in a pulsatile manner without the drug affinity complex (DAC) that extends half-life to several days—allowing for more physiological pulsatile release. Ipamorelin is a selective growth hormone-releasing peptide (GHRP) that acts on the ghrelin receptor, stimulating GH release with minimal effects on cortisol, prolactin, and appetite. Research published in the NIH PubMed database demonstrates that the combination of a GHRH analog with a GHRP produces a synergistic GH response significantly greater than either compound alone, mimicking the natural interplay of GHRH and ghrelin in the body.

The relevance of this blend to the athletic and bodybuilding community is substantial. Growth hormone plays a critical role in protein synthesis, collagen formation, lipolysis, and immune function. The CJC 1295/Ipamorelin combination supports enhanced recovery from intense training, improved sleep architecture, better preservation of lean muscle mass during caloric deficits, and accelerated repair of connective tissue. Unlike more potent GHRPs, Ipamorelin offers a clean side effect profile without significant increases in cortisol or prolactin, making it ideal for long-term research protocols. The addition of CJC 1295 No DAC amplifies the GH pulse while maintaining physiological pulsatility.

Quality assurance is paramount in peptide research. Each batch of our CJC 1295 No DAC/Ipamorelin inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. The most recent batch (November 2025) tested at 5.93 mg of CJC 1295 No DAC and 4.96 mg of Ipamorelin with batch number #HDCI10, demonstrating Dragon Pharma's commitment to quality and consistency. This level of transparency ensures that researchers can trust the integrity of the compounds they are investigating.

For bodybuilders and strength athletes navigating the demands of intense training cycles, the CJC 1295 No DAC/Ipamorelin blend offers a sophisticated research tool for supporting growth hormone pathways. The pre-mixed formulation eliminates the need to reconstitute two separate vials, simplifying research protocols and ensuring consistent ratios. Whether investigating strategies for accelerated recovery, improved sleep quality, or lean muscle preservation, Dragon Pharma's CJC 1295 No DAC/Ipamorelin blend delivers the purity, potency, and reliability required for serious research into growth hormone modulation.

Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.

Product Specifications

Usage Guidelines

This CJC 1295 No DAC/Ipamorelin blend is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 10mg blend (5mg each) with 2-4mL of bacteriostatic water, yielding a concentration of 2.5-5mg/mL total peptide (1.25-2.5mg/mL of each peptide). Typical research dosing for this blend ranges from 200-500mcg of each peptide per administration (400-1000mcg total), often administered 1-2 times daily via subcutaneous injection. For optimal GH pulsatility, administer on an empty stomach, waiting at least 2 hours after meals and 30 minutes before eating. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity.

For researchers investigating comprehensive growth hormone modulation protocols, combining this blend with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:

• GHRP-2: A more potent GHRP for comparative research on GH stimulation profiles.
• MK 677: An oral growth hormone secretagogue for comparative research on pulsatile vs. sustained GH elevation.
• IGF-1 LR3: An insulin-like growth factor for research on downstream anabolic pathways.

Third-Party Lab Results

2025-11-07

View Certificate

5.93 mg / 4.96 mg

Shipping & Authenticity

• From USA Domestic warehouse: 2-5 business days.
• From International warehouse: 14-21 business days.
• Free and automatic re-shipping policy if package doesn't reach destination within 30 days.
• Original product directly from manufacturer.
• We accept credit cards and cryptocurrency—crypto payments receive an additional 20% discount at checkout.

Storage Instructions

To maintain maximum stability and potency of the lyophilized powder, store the unopened vial in a freezer at -20°C (-4°F) away from light. Upon reconstitution with bacteriostatic water, the solution must be stored in a refrigerator at 2-8°C (36-46°F) and should be used within 30 days. Avoid repeated freeze-thaw cycles as this may degrade the peptide structure.

Frequently Asked Questions